Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026

Inclusion criteria

• 18 years of age or older
• Subject has given written informed consent to participate in the study

Exclusion criteria

• (*) Pregnant or positive human chorionic gonadotropin (hCG) test
• (*) Any severe coagulopathy, chronic bleeding disorders (i.e., hemophilia) or recent thrombolysis
• (*) Hemoglobinopathies and synthesis disorders (i.e., sickle cell, thalassemias, etc.)
• (*) Subjects who are currently taking anticoagulant medication
• (*) Subjects with allergies to lidocaine, Pain Ease, latex, adhesives, or plastic
• (*) Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as psoriasis, eczema, angioma, burns, scar tissue, substantial skin breakdown, nail polish, acrylic nails, infections, abnormalities, etc.
• (*) Subjects unlikely to be able to refrain from excessive motion during data collection. Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.
• (*) Subjects with elevated blood pressure, skin or wrist abnormalities that may interfere with an arterial blood draw as determined by investigator or research medical staff.
• (*) Subjects who intend on participating in heavy lifting, repetitive movement of their wrist (including riding a motorcycle) or exercise (working out, riding a bike, etc.), or any activity that will put additional stress on the wrist within 24 hours following a study involving an arterial blood draw
• Subjects deemed not suitable for the study at the discretion of the investigator or research medical staff

Note: (*) May be self-reported by subject